IDYA
Ideaya Biosciences Inc
36.70$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +21.8% | +48.1% | +1.3% | +27.3% | -9.3% | -2.1% | -5.4% | +13.8% | -6.4% | -7.1% | +27.1% | |
| – | +10.5% | +33.2% | +0.5% | +30.7% | -26.0% | +2.6% | -3.1% | +17.1% | -16.9% | +4.4% | +24.1% | |
| – | +3.4% | -31.0% | +69.0% | +118.7% | -78.9% | +54.1% | -11.8% | +160.7% | -62.3% | +39.6% | +73.0% | |
| – | +12.0% | +33.1% | +0.4% | +31.1% | -26.5% | +2.4% | -3.3% | +17.5% | -18.7% | +5.0% | +23.5% | |
| – | -99.7% | -16.7% | -93.3% | +1,900.0% | -85.0% | – | – | – | – | +9.8% | +135.0% | |
| – | – | -100.0% | +0.0% | – | – | – | – | – | – | – | – | |
| – | +13.4% | -7.1% | +60.2% | +41.5% | +9.2% | +17.8% | +6.7% | +14.1% | -7.2% | +7.7% | +19.0% | |
| – | +8.9% | -7.9% | +63.2% | -0.2% | +13.3% | +10.4% | +8.8% | +16.6% | -8.8% | +10.2% | +27.5% | |
| – | -16.7% | -34.1% | -47.4% | – | – | +3.4% | +3.2% | +3.1% | +3.4% | +3.2% | +240.0% | |
| – | +27.6% | -4.7% | +152.6% | -20.9% | +22.7% | +14.3% | -2.0% | +6.7% | -4.6% | +17.9% | +47.1% | |
| – | +22.3% | +50.6% | -0.4% | +26.7% | -10.3% | -3.3% | -6.3% | +13.8% | -6.3% | -8.4% | +27.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.7% | +15.1% | +3.8% | +10.6% | +1.3% | +1.2% | +0.1% | +1.4% | -1.2% | +0.1% | +3.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.